PortfoliosLab logoPortfoliosLab logo
PZG vs. RAPT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PZG vs. RAPT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Paramount Gold Nevada Corp. (PZG) and RAPT Therapeutics, Inc. (RAPT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


PZG

1D
-5.76%
1M
-5.07%
YTD
3.97%
6M
12.93%
1Y
124.39%
3Y*
65.31%
5Y*
4.52%
10Y*
-0.89%

RAPT

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

PZG vs. RAPT - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
PZG
Paramount Gold Nevada Corp.
3.97%268.42%-8.80%8.70%-50.62%-40.29%51.28%11.49%
RAPT
RAPT Therapeutics, Inc.
71.30%167.96%-93.64%25.51%-46.09%85.97%-28.47%112.38%

Correlation

The correlation between PZG and RAPT is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.06

Correlation (5Y)
Calculated over the trailing 5-year period

0.08

Correlation (All Time)
Calculated using the full available price history since Nov 1, 2019

0.07

Fundamentals

Market Cap

PZG:

$108.90M

RAPT:

$1.56B

EPS

PZG:

-$0.09

RAPT:

-$3.92

PB Ratio

PZG:

3.08

RAPT:

10.29

Total Revenue (TTM)

PZG:

$0.00

RAPT:

$0.00

Gross Profit (TTM)

PZG:

-$892.14K

RAPT:

-$200.00K

EBITDA (TTM)

PZG:

-$11.01M

RAPT:

-$108.01M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PZG vs. RAPT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PZG
PZG Risk / Return Rank: 8080
Overall Rank
PZG Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
PZG Sortino Ratio Rank: 8383
Sortino Ratio Rank
PZG Omega Ratio Rank: 7878
Omega Ratio Rank
PZG Calmar Ratio Rank: 7878
Calmar Ratio Rank
PZG Martin Ratio Rank: 7878
Martin Ratio Rank

RAPT
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PZG vs. RAPT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Paramount Gold Nevada Corp. (PZG) and RAPT Therapeutics, Inc. (RAPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PZGRAPTDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.29

Calmar ratioReturn relative to maximum drawdown

2.44

Martin ratioReturn relative to average drawdown

5.77

PZG vs. RAPT - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


PZGRAPTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.75

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.07

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.01

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.08

Drawdowns

PZG vs. RAPT - Drawdown Comparison


Loading charts...

Drawdown Indicators


PZGRAPTDifference

Max Drawdown

Largest peak-to-trough decline

-93.81%

Max Drawdown (1Y)

Largest decline over 1 year

-51.31%

Max Drawdown (3Y)

Largest decline over 3 years

-51.31%

Max Drawdown (5Y)

Largest decline over 5 years

-74.05%

Max Drawdown (10Y)

Largest decline over 10 years

-90.14%

Current Drawdown

Current decline from peak

-70.36%

Average Drawdown

Average peak-to-trough decline

-68.57%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.65%

Volatility

PZG vs. RAPT - Volatility Comparison


Loading charts...

Volatility by Period


PZGRAPTDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.41%

Volatility (6M)

Calculated over the trailing 6-month period

57.14%

Volatility (1Y)

Calculated over the trailing 1-year period

71.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

62.66%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.65%

Dividends

PZG vs. RAPT - Dividend Comparison

Neither PZG nor RAPT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

PZG vs. RAPT - Financials Comparison

This section allows you to compare key financial metrics between Paramount Gold Nevada Corp. and RAPT Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00K400.00K600.00K800.00K1.00M1.20M2022202320242025202600
(PZG) Total Revenue
(RAPT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


PZG and RAPT have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for PZG and RAPT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer